Tag: Cancer
-
Fluorescent Label Passes Through Blood-Brain Barrier
Fluorescent indocarbocyanine lipid labels show improved distribution within glioblastoma brain tumors, according to a Northwestern Medicine study.
-
Gene Implicated in Poor Skin Cancer Therapy Outcomes
Losing a check on T-cell activation in cutaneous T-cell lymphoma cells is associated with poor outcomes, according to a study published in Blood.
-
Using Circulating Tumor DNA to Target Immunotherapy
Using circulating tumor DNA to identify patients at risk for urothelial cancer relapse after surgical resection could help improve post-surgery treatment, according to a new study.
-
Nanoparticles Could Boost Immunotherapy
Enhancing the anti-cancer function of natural killer cells with nanoparticles could unlock their therapeutic potential, according to a Northwestern Medicine study.
-
Combined Therapy Shows Promise for Chronic Lymphocytic Leukemia
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.
-
Novel Therapy May Improve Survival for Malignant Gliomas
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
-
Virtual Intervention Reduces Fear of Breast Cancer Recurrence
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
-
Novel Treatments to Prevent Infections in Patients with Leukemia
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
-
Predicting Which Patients Will Discontinue Breast Cancer Therapy
A Northwestern Medicine study has found that women with hormone receptor-positive breast cancer were more likely to discontinue hormone therapy early due to poor quality of life-related outcomes.
-
Immunosuppression Drug Could Reduce Chemotherapy Resistance
A drug currently used to prevent organ rejection in transplants could also reduce chemotherapy resistance in glioblastoma, according to a Northwestern Medicine study.
